Encontrados 5 documentos, a visualizar página 1 de 1
The scintillation and ionization yield of liquid xenon for nuclear recoils
Sorensen, P.; Manzur, A.; Dahl, C. E.; Angle, J.; Aprile, E.; Arneodo, F.; Baudis, L.; Bernstein, A.; Bolozdynya, A.; Coelho, L. C. C.; DeViveiros, L.http://www.sciencedirect.com/science/article/B6TJM-4VBDGYK-3/2/955ce6ee62330f437f352d46bbc8f500
XENON
Aprile, E.; Giboni, K.-L.; Monzani, M. E.; Plante, G.; Yamashita, M.; Gaitskell, R. J.; Fiorucci, S.; Sorensen, P.; DeViveiros, L.; Bernstein, A.The XENON experiment aims at the direct detection of dark matter in the form of WIMPs (Weakly Interacting Massive Particles) via their elastic scattering off Xenon nuclei. With 1 ton of LXe distributed in ten identical modules, the proposed XENON1T experiment will achieve a sensitivity more than a factor of thousand beyond current limits.The detectors are time projection chambers operated in dual (liquid/gas) p...
3D Position Sensitive XeTPC for Dark Matter Search
Angle, J.; Aprile, E.; Arneodo, F.; Baudis, L.; Bernstein, A.; Bolozdynya, A.; Coelho, L.; Dahl, E.; DeViveiros, L.; Ferella, A.; Fernandes, L.The technique to realize 3D position sensitivity in a two-phase xenon time projection chamber (XeTPC) is described. Results from a prototype detector (XENON3) are presented. ; http://www.sciencedirect.com/science/article/B6TVD-4R68DXJ-13/1/c7a25befd9bec275706d42709c6eb3c6
Acute effect of different antidepressants on glycemia in diabetic and non-diabe...
Gomez,R.; Huber,J.; Tombini,G.; Barros,H.M.T.Diabetic patients have a 20% higher risk of depression than the general population. Treatment with antidepressant drugs can directly interfere with blood glucose levels or may interact with hypoglycemic agents. The treatment of depression in diabetic patients must take into account variations of glycemic levels at different times and a comparison of the available antidepressant agents is important. In the prese...
Plasma insulin levels are increased by sertraline in rats under oral glucose ov...
Gomez,R.; Huber,J.; Lhullier,F.; Barros,H.M.T.Recognition and control of depression symptoms are important to increase patient compliance with treatment and to improve the quality of life of diabetic patients. Clinical studies indicate that selective serotonin reuptake inhibitors (SSRI) are better antidepressants for diabetic patients than other drugs. However, preclinical trials have demonstrated that not all SSRI reduce plasma glucose levels. In fact, fl...
| Financiadores do RCAAP | |||||||
|
|
|
|
|
|
||